{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:29:42Z","timestamp":1790418582688,"version":"4.1.0"},"reference-count":35,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The absorption study of drugs through different biological membranes constitutes an essential step in the development of new pharmaceutical dosage forms. Concerning orally administered forms, methods based on monolayer cell culture of Caco-2 (Caucasian colon adenocarcinoma) have been developed to emulate intestinal mucosa in permeability studies. Although it is widely accepted, it has disadvantages, such as high costs or high technical complexity, and limitations related to the simplified structure of the monolayer or the class of molecules that can be permeated according to the transport mechanisms. The aim of this work was to develop a new ex vivo methodology which allows the evaluation of the intestinal apparent permeability coefficient (Papp) while using fewer resources and to assess the correlation with Caco-2. To this end, pig (Sus scrofa) duodenum segments were mounted in Franz diffusion cells and used to permeate four different drugs: ketorolac tromethamine (Kt), melatonin (Mel), hydrochlorothiazide (Htz), and furosemide (Fur). No statistically significant differences (p &gt; 0.05) were observed corelating Papp values from Franz diffusion cells and Caco-2 cell experiments for Kt, Htz, and Fur. However, there were statistically significant differences (p &lt; 0.05) correlating Papp values and Mel. The difference is explained by the role of Mel in the duodenal epithelial paracellular permeability reduction. Ex vivo permeation may be an equivalent method to Caco-2 for drugs that do not produce intestinal membrane phenomena that could affect absorption.<\/jats:p>","DOI":"10.3390\/pharmaceutics11120638","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T10:58:21Z","timestamp":1575025101000},"page":"638","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments"],"prefix":"10.3390","volume":"11","author":[{"given":"Aroha","family":"B. S\u00e1nchez","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-4821","authenticated-orcid":false,"given":"Ana","family":"C. Calpena","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-8459","authenticated-orcid":false,"given":"Mireia","family":"Mallandrich","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-7890","authenticated-orcid":false,"given":"Beatriz","family":"Clares","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sugano, K. (2012). Biopharmaceutics Modeling and Simulations: Theory, Practice, Methods, and Applications, John Wiley & Sons, Inc.. [1st ed.].","DOI":"10.1002\/9781118354339"},{"key":"ref_2","first-page":"235","article-title":"A general approach to the apparent permeability index","volume":"35","author":"Palumbo","year":"2008","journal-title":"J. Pharm. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(95)04204-0","article-title":"Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo","volume":"127","author":"Palm","year":"1996","journal-title":"Int. J. Pharm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhazmat.2018.09.053","article-title":"Adducts formed during protein digestion decreased the toxicity of five carbonyl compounds against Caco-2 cells","volume":"363","author":"Jiang","year":"2019","journal-title":"J. Hazard. Mater."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.fct.2019.03.047","article-title":"Cyanidin chloride modestly protects Caco-2 cells from ZnO nanoparticle exposure probably through the induction of autophagy","volume":"127","author":"Jiang","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Juan-Garc\u00eda, A., Montesano, D., Ma\u00f1es, J., and Juan, C. (2019). Cytoprotective effects of carotenoids-rich extract from Lycium barbarum L. on the beauvericin-induced cytotoxicity on Caco-2 cells. Food Chem. Toxicol., 133.","DOI":"10.1016\/j.fct.2019.110798"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.foodres.2019.02.029","article-title":"In-vitro antioxidant capacity and cytoprotective\/cytotoxic effects upon Caco-2 cells of red tilapia (Oreochromis spp.) viscera hydrolysates","volume":"120","author":"Zapata","year":"2019","journal-title":"Food Res. Int."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, Q., Liang, X., Guo, N., Hu, L., E, M.P., Wu, Y., and Wang, K. (2019). Protective effects of Bee pollen extract on the Caco-2 intestinal barrier dysfunctions induced by dextran sulfate sodium. Biomed. Pharmacother., 117.","DOI":"10.1016\/j.biopha.2019.109200"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.addr.2016.08.007","article-title":"In vitro toxicity assessment of oral nanocarriers","volume":"106","author":"Ciappellano","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijbiomac.2019.07.168","article-title":"Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers","volume":"138","author":"Dou","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jddst.2019.05.040","article-title":"Internalization and subcellular transport mechanisms of different curcumin loaded nanocarriers across Caco-2 cell model","volume":"52","author":"Yan","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lu, C., Fu, K., Cao, K., Wei, J., Zhou, J., Zhao, D., and Zhang, Y. (2019). Permeability and transport mechanism of trihexyphenidyl hydrochloride in Caco-2 cell monolayer model with a validated UPLC-MS\/MS method. J. Pharm. Biomed. Anal.","DOI":"10.1016\/j.jpba.2019.112924"},{"key":"ref_13","first-page":"3924","article-title":"Oral delivery of highly lipophilic poorly water-soluble drugs: spray-dried dispersions to improve oral absorption and enable high-dose toxicology studies of a P2Y1 antagonist","volume":"12","author":"Stefanski","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejps.2016.12.018","article-title":"Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant","volume":"99","author":"Bu","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1021\/acsami.6b00821","article-title":"Transport mechanisms of solid lipid nanoparticles across Caco-2 cell monolayers and their related cytotoxicology","volume":"8","author":"Chai","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1056-8719(01)00161-7","article-title":"Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis","volume":"46","author":"Markowska","year":"2001","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_18","unstructured":"(2018). Committee for Human Medicinal Products. ICH guideline M9 on biopharmaceutics classification system based biowaivers, European Medicines Agency."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Welcome, M.O. (2018). Gastrointestinal Physiology, Springer. [1st ed.].","DOI":"10.1007\/978-3-319-91056-7"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Krishna, R., and Yu, L. (2008). Evaluation of permeability and P-glycoprotein interactions: Industry outlook. Biopharmaceutics Applications in Drug Development, Springer Science + Business Media, LLC. [1st ed.].","DOI":"10.1007\/978-0-387-72379-2"},{"key":"ref_21","first-page":"501","article-title":"Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: Species- and region-related differences","volume":"35","author":"Nejdfors","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_22","unstructured":"United States Pharmacopeial Convention (2006). USP DI, United States Pharmacopeial Convention. [21th ed.]. Parts 1\u20132; Volumes 2\u20133."},{"key":"ref_23","unstructured":"R\u00f6msing, S. (2010). Development and Validation of Bioanalytical Methods, Application to Melatonin and Selected Anti-Infective Drugs. [Ph.D. Thesis, Uppsala University]."},{"key":"ref_24","unstructured":"O\u2019Neil, M.J., Smith, A., Henckelman, P.E., and Budavari, S. (2001). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co., Inc.. [13th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chemosphere.2003.07.001","article-title":"Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations","volume":"54","author":"Khan","year":"2004","journal-title":"Chemosphere"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpba.2005.12.020","article-title":"Prediction of the permeability of drugs through study on quantitative structure-permeability relationship","volume":"41","author":"Jung","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-079X.1997.tb00302.x","article-title":"Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications","volume":"22","author":"Yeleswaram","year":"1997","journal-title":"J. Pineal Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yazdanian, M., Glynn, S.L., Wright, J.L., and Hawi, A. (1998). Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm. Res., 15.","DOI":"10.1023\/A:1011930411574"},{"key":"ref_29","first-page":"57","article-title":"Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation","volume":"21","author":"Bock","year":"2004","journal-title":"ALTEX"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000109445","article-title":"regional and diurnal studies of melatonin and melatonin binding sites in the duck gastro-intestinal tract","volume":"4","author":"Lee","year":"1995","journal-title":"Neurosignals"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"S\u00f6derquist, F., Hellstr\u00f6m, P.M., and Cunningham, J.L. (2015). Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120195"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mayo, J.C., Aguado, A., Cernuda-Cernuda, R., \u00c1lvarez, A., Cepas, V., Gonz\u00e1lez, I.Q., and Rosa, M.S. (2018). Melatonin uptake by cells: An answer to its relationship with glucose?. Molecules, 23.","DOI":"10.3390\/molecules23081999"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jpi.12013","article-title":"Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor \u2013 dependent pathway in rats in vivo","volume":"54","author":"Res","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2009.05.024","article-title":"New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments","volume":"378","author":"Tran","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.micron.2013.12.003","article-title":"Ultrastructural aspects of melatonin cytotoxicity on Caco-2 cells in vitro","volume":"59","author":"Batista","year":"2014","journal-title":"Micron"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/12\/638\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:50Z","timestamp":1760189930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/12\/638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["pharmaceutics11120638"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics11120638","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]}}}